ENFN Annual Cash & Cash Equivalents
$35.60 M
-$26.94 M-43.07%
31 December 2023
Summary:
As of January 22, 2025, ENFN annual cash & cash equivalents is $35.60 million, with the most recent change of -$26.94 million (-43.07%) on December 31, 2023. During the last 3 years, it has risen by +$21.67 million (+155.45%). ENFN annual cash & cash equivalents is now -44.68% below its all-time high of $64.36 million, reached on December 31, 2021.ENFN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENFN Quarterly Cash And Cash Equivalents
$48.30 M
+$13.85 M+40.21%
30 September 2024
Summary:
As of January 22, 2025, ENFN quarterly cash and cash equivalents is $48.30 million, with the most recent change of +$13.85 million (+40.21%) on September 30, 2024. Over the past year, it has increased by +$16.65 million (+52.59%). ENFN quarterly cash and cash equivalents is now -24.96% below its all-time high of $64.36 million, reached on December 31, 2021.ENFN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENFN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.1% | +52.6% |
| 3 y3 years | +155.4% | +52.6% |
| 5 y5 years | +503.7% | +52.6% |
ENFN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.7% | at low | -25.0% | +73.9% |
| 5 y | 5-year | -44.7% | +503.7% | -25.0% | +472.8% |
| alltime | all time | -44.7% | +503.7% | -25.0% | +472.8% |
Enfusion Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.30 M(+40.2%) |
| June 2024 | - | $34.45 M(+4.7%) |
| Mar 2024 | - | $32.89 M(-7.6%) |
| Dec 2023 | $35.60 M(-43.1%) | $35.60 M(+12.5%) |
| Sept 2023 | - | $31.65 M(+14.0%) |
| June 2023 | - | $27.77 M(-49.1%) |
| Mar 2023 | - | $54.60 M(-12.7%) |
| Dec 2022 | $62.55 M | $62.55 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $63.54 M(+12.3%) |
| June 2022 | - | $56.56 M(+0.6%) |
| Mar 2022 | - | $56.21 M(-12.7%) |
| Dec 2021 | $64.36 M(+361.8%) | $64.36 M(+663.3%) |
| Sept 2021 | - | $8.43 M(-41.9%) |
| June 2021 | - | $14.52 M(+4.1%) |
| Dec 2020 | $13.94 M(+136.3%) | $13.94 M |
| Dec 2019 | $5.90 M | - |
FAQ
- What is Enfusion annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Enfusion?
- What is Enfusion annual cash & cash equivalents year-on-year change?
- What is Enfusion quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Enfusion?
- What is Enfusion quarterly cash and cash equivalents year-on-year change?
What is Enfusion annual cash & cash equivalents?
The current annual cash & cash equivalents of ENFN is $35.60 M
What is the all time high annual cash & cash equivalents for Enfusion?
Enfusion all-time high annual cash & cash equivalents is $64.36 M
What is Enfusion annual cash & cash equivalents year-on-year change?
Over the past year, ENFN annual cash & cash equivalents has changed by -$26.94 M (-43.07%)
What is Enfusion quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ENFN is $48.30 M
What is the all time high quarterly cash and cash equivalents for Enfusion?
Enfusion all-time high quarterly cash and cash equivalents is $64.36 M
What is Enfusion quarterly cash and cash equivalents year-on-year change?
Over the past year, ENFN quarterly cash and cash equivalents has changed by +$16.65 M (+52.59%)